Roles and mechanisms of alternative splicing in cancer—implications for care
SC Bonnal, I López-Oreja, J Valcárcel - Nature reviews Clinical …, 2020 - nature.com
Removal of introns from messenger RNA precursors (pre-mRNA splicing) is an essential
step for the expression of most eukaryotic genes. Alternative splicing enables the regulated …
step for the expression of most eukaryotic genes. Alternative splicing enables the regulated …
Targeting PI3K in cancer: mechanisms and advances in clinical trials
Abstract Phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR)
signaling is one of the most important intracellular pathways, which can be considered as a …
signaling is one of the most important intracellular pathways, which can be considered as a …
The PI3K-AKT-mTOR pathway and prostate cancer: at the crossroads of AR, MAPK, and WNT signaling
BY Shorning, MS Dass, MJ Smalley… - International journal of …, 2020 - mdpi.com
Oncogenic activation of the phosphatidylinositol-3-kinase (PI3K), protein kinase B
(PKB/AKT), and mammalian target of rapamycin (mTOR) pathway is a frequent event in …
(PKB/AKT), and mammalian target of rapamycin (mTOR) pathway is a frequent event in …
[HTML][HTML] The role of alternative splicing in cancer: From oncogenesis to drug resistance
R Sciarrillo, A Wojtuszkiewicz, YG Assaraf… - Drug Resistance …, 2020 - Elsevier
Alternative splicing is a tightly regulated process whereby non-coding sequences of pre-
mRNA are removed and protein-coding segments are assembled in diverse combinations …
mRNA are removed and protein-coding segments are assembled in diverse combinations …
[HTML][HTML] Integrated analysis of genetic ancestry and genomic alterations across cancers
Disparities in cancer care have been a long-standing challenge. We estimated the genetic
ancestry of The Cancer Genome Atlas patients, and performed a pan-cancer analysis on the …
ancestry of The Cancer Genome Atlas patients, and performed a pan-cancer analysis on the …
The landscape of atypical and eukaryotic protein kinases
GK Kanev, C de Graaf, IJP de Esch, R Leurs… - Trends in …, 2019 - cell.com
Kinases are attractive anticancer targets due to their central role in the growth, survival, and
therapy resistance of tumor cells. This review explores the two primary kinase classes, the …
therapy resistance of tumor cells. This review explores the two primary kinase classes, the …
Aberrant RNA splicing in cancer and drug resistance
BD Wang, NH Lee - Cancers, 2018 - mdpi.com
More than 95% of the 20,000 to 25,000 transcribed human genes undergo alternative RNA
splicing, which increases the diversity of the proteome. Isoforms derived from the same gene …
splicing, which increases the diversity of the proteome. Isoforms derived from the same gene …
Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry
O Sartor, AJ Armstrong, C Ahaghotu… - Prostate cancer and …, 2020 - nature.com
Abstract Purpose African Americans experience greater prostate cancer risk and mortality
than do Caucasians. An analysis of pooled phase III data suggested differences in overall …
than do Caucasians. An analysis of pooled phase III data suggested differences in overall …
Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry
Men of predominantly African Ancestry (AA) have higher prostate cancer (CaP) incidence
and worse survival than men of predominantly European Ancestry (EA). While …
and worse survival than men of predominantly European Ancestry (EA). While …
Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics
The largest US cancer health disparity exists in prostate cancer, with Black men having more
than a two-fold increased risk of dying from prostate cancer compared to all other races. This …
than a two-fold increased risk of dying from prostate cancer compared to all other races. This …